15:55 May 29

Orchid Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
792.50
+31.15 (+4.09%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Orchid Pharma Ltd. Financials

Orchid Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
792.50
+31.15 (+4.09%)
15:55 May 29
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

30/100
Mid Valuation

Technical

56/100
Technically Neutral

Strength

9

Weakness

9

Opportunity

1

Threats

1

1.59 %

ROE %

1.07 %

ROA %

4.01

EPS

253.90

BVPS

2.53 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
559.56 665.9 819.37 921.93 811.33
Operating Expenses +
506.43 582.27 708.7 804.75 770.2
Raw Material
340.62 406.1 528.35 588.07 464.03
Increase Decrease in Cost
-27.06 -21.48 -43.89 -43.85 61.85
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
63.28 65.35 69.64 86.36 91.47
Miscellaneous Expenses
129.59 132.3 154.6 179.39 156.23
Operating Profit
53.13 83.63 110.67 117.18 41.13
Other Income
9 19.43 30.86 27.47 35.17
Depreciation
87.02 54.79 33.24 34.55 35.45
Interest
32.01 32.23 16.35 14.54 13.26
Profit before tax and exceptio..
-56.9 16.04 91.95 95.56 27.59
Exceptional Items
0 39.21 0 0 -6.57
PBT
-56.9 55.25 91.95 95.56 21.02
Provision for Taxation
0 0 -3.12 -0.19 -0.19
Net Profit
1.57 48.47 95.06 95.76 21.21
NET Profit after MI
-1.95 46.32 92.17 99.66 20.55
EPS
-0.48 11.35 19.06 19.65 4.05
Operating Profit Margin (%)
9.5 12.56 13.51 12.71 5.07
Net Profit Margin (%)
-0.35 6.96 11.25 10.81 2.53

Orchid Pharma Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: